Our research by region
We invest in world-class blood cancer research all over the UK. Below you can find out more about some of the research going on in your region.
London and South East
Our research in London and the South East of England is revealing how blood cancer works, driving smarter and faster diagnosis, and inspiring new treatments and care. Last year we made 18 new awards to research going on in this region and we have Trials Acceleration Programme (TAP) centres in Oxford and at King’s College, Hammersmith and Bart’s hospitals.
Birmingham and the Midlands are really important to us. Our TAP hub is based in Birmingham as well as centres in Birmingham and Nottingham. Last year we made eight new awards to researchers in the region.
Lots of exciting research is going on in the North, and two of our key ‘infrastructure’ projects are based in the region. Yorkshire is home to the Haematological Malignancy Research Network, which provides the most accurate and detailed data on all types of blood cancers in the world, broken down by key demographics and biological features. The Childhood Leukaemia CellBank is based in Stockport – it’s a central UK repository for samples of bone marrow and other tissues donated by children with leukaemia, for use in specialist research projects. Last but not least we have three TAP centres in Leeds, Manchester and Liverpool.
Our research in Scotland is revealing how blood cancer works, driving smarter and faster diagnosis, and inspiring new treatments and care. Our innovative Trials Acceleration Programme has a centre based in Glasgow.
Our research in the South West is based around the universities of Southampton, Bristol and Plymouth. Work going on at these institutions will help patients with many different types of blood cancers. We also have a TAP centre in Southampton and special genetics laboratory in Salisbury.
Some of our most exciting research is going on in Wales, particularly around chronic lymphocytic leukaemia. We have a TAP centre in Cardiff and last year awarded one new grant in the country.
Our research in Northern Ireland is revealing how acute myeloid leukaemias and related conditions develop, so we can design new treatments and better care. There's also a TAP centre in Belfast.